CCP
EXAS

Cassia Capital Partners’s Exact Sciences EXAS Stock Holding History

Cassia Capital Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,105
Closed -$487K – 97
2021
Q3 		$487K Buy
+5,105
New +$539K 0.34% 79

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cassia Capital Partners's EXAS Position: Q4 2021 in Review

Cassia Capital Partners sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 5,105 shares — an estimated $487K sold.

Cassia Capital Partners first reported a position in EXAS in Q3 2021 and held it in 1 quarter. The position peaked at $487K in Q3 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Cassia Capital Partners reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Cassia Capital Partners sold 5,105 Exact Sciences shares in Q4 2021, an estimated $487K.
  • Cassia Capital Partners first reported a position in Exact Sciences in Q3 2021 and held it in 1 quarter.
  • Cassia Capital Partners's Exact Sciences position peaked at $487K in Q3 2021.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Cassia Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.